天然产物研究与开发 ›› 2024, Vol. 36 ›› Issue (8): 1393-1400.doi: 10.16333/j.1001-6880.2024.8.013

• 开发研究 • 上一篇    下一篇

刺糖多糖调控Toll样受体4对免疫抑制活性的影响

吕志远1,宋建忠1,2,曲真真1,李进发1,李改茹1,常军民1, 3*   

  1. 1新疆医科大学药学院,乌鲁木齐 830000;2新疆医科大学附属肿瘤医院药学部,乌鲁木齐 830011;3新疆天然药物活性组分与释药技术重点实验室,乌鲁木齐 830000
  • 出版日期:2024-08-28 发布日期:2024-08-29
  • 基金资助:
    国家自然科学基金(82060756)

Effect ofAlhagi honey polysaccharide on immunosuppressive activity by regulating Toll-like receptor 4

LYU Zhi-yuan1,SONG Jian-zhong1,2, QU Zhen-zhen1,LI Jin-fa1,LI Gai-ru1,CHANG Jun-min1,3*   

  1. 1College of Pharmacy,Xinjiang Medical University,Urumqi 830000,China;2Department of Pharmacy,Affiliated Tumor Hospital of Xinjiang Medical University,Urumqi 830011,China;3Xinjiang Key Laboratory of Natural Medicines Active Components and Drug Release Technology,Urumqi 830000,China
  • Online:2024-08-28 Published:2024-08-29

摘要:

揭示刺糖多糖对Toll样受体4(Toll-like receptor 4,TLR4)的调控机制。构建C57BL/6J免疫抑制小鼠模型及TAK-242抑制剂诱导的RAW 264.7模型,小鼠模型给予刺糖多糖组800 mg/kg以及RAW 264.7模型给予不同浓度的刺糖多糖(25、50、75、100 μg/mL)进行干预。酶联免疫吸附测定法(enzyme-linked immunosorbent assay,ELISA)分别测定小鼠血清中细胞因子、RAW 264.7细胞因子分泌水平。蛋白免疫印迹(Western blot)与实时荧光定量PCR(real-time quantitative PCR,qRT-PCR)法检测TLR4和髓样分化因子88(myeloiddifferentiationfactor88,MyD88)与肿瘤坏死因子相关的分子6(TNF receptor associated factor 6,TRAF6)在相关组织和细胞中的表达。结果表明刺糖多糖显著提高了免疫抑制小鼠的脾脏指数、胸腺指数,以及血清中白细胞介素-2(interleukin-2,IL-2)、白细胞介素-4(interleukin-4,IL-4)、肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)、免疫球蛋白G(Immunoglobulin G,IgG)和免疫球蛋白M(Immunoglobulin M,IgM)的含量。在TAK-242抑制剂诱导的细胞模型中,刺糖多糖增加了白细胞介素-1β(Interleukin-1β,IL-1β)、白细胞介素-6(Interleukin- 6,IL-6)、白细胞介素-12(interleukin-12,IL-12)、TNF-α、核因子κB(nuclear factor-κB,NF-κB)的分泌。此外,刺糖多糖逆转了TLR4和MyD88/TRAF6的表达下调。刺糖多糖可以通过调节MyD88途径激活TLR4受体的免疫应答。

关键词: 刺糖多糖, Toll样受体4, 巨噬细胞RAW 264.7, 免疫抑制

Abstract:

This study elucidates the regulatory mechanism of Alhagi honey polysaccharide on Toll-like receptor 4 (TLR4).An immunosuppressive mouse model was established using C57BL/6J mice,and a RAW 264.7 model induced by TAK-242 inhibitor was constructed.In the mouse model,Alhagi honey polysaccharide were administered at 800 mg/kg,while the RAW 264.7 model received interventions with different concentrations of Alhagi honey polysaccharide (25,50,75,100 μg/mL).Enzyme-linked immunosorbent assay (ELISA) was employed to measure cytokine levels in mouse serum and RAW 264.7 cell culture supernatant.Protein immunoblotting and real-time quantitative PCR (qRT-PCR) were conducted to detect the expression of TLR4,myeloid differentiation factor 88 (MyD88),and tumor necrosis factor-α receptor associated factor 6 (TRAF6) in relevant tissues and cells.Results indicate that Alhagi honey polysaccharide significantly increased the spleen index,thymus index,and serum levels of interleukin-2 (IL-2),interleukin-4 (IL-4),tumor necrosis factor-α (TNF-α),immunoglobulin G (IgG),and immunoglobulin M (IgM) in immunosuppressive mice.In the TAK-242 inhibitor-induced cell model,Alhagi honey polysaccharide increased the secretion of interleukin-1β (IL-1β),interleukin-6 (IL-6),interleukin-12 (IL-12),TNF-α,and nuclear factor-κB (NF-κB).Furthermore,Alhagi honey polysaccharide reversed the downregulation of TLR4 and MyD88/TRAF6 expression.Alhagi honey polysaccharide can activate the immune response of TLR4 receptors by modulating the MyD88 pathway.

Key words: Alhagi honey polysaccharide, Toll-like receptor 4, macrophage RAW 264.7, immunosuppression

中图分类号:  R967